You are here: Industry Insights > Diabetes

News List

Lilly's Tirzepatide Reduced A1C, Body Weight for Type 2 Diabetes americanpharmaceuticalreview
December 10, 2020
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results from Eli Lilly and Company's SURPASS-1 monotherapy clinical trial evaluating the efficacy and safety ...
AstraZeneca signs MoU with RSSDI to empower one crore Indian Diabetic patients by 2023 expresspharma
November 27, 2020
This initiative will empower patients/caregivers to have conversations around Diabetes and make informed decisions about the management of the disease.
Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin expresspharma
November 25, 2020
The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80.
Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores prnasia
November 17, 2020
Happiness Biotech Group Limited announced that the Company's experience stores started offering Coenzyme Q10 - a best-selling product from Xiamen Kingdomway Group Company.
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific prnasia
November 11, 2020
Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
Drug used to treat opioid addiction can reverse some adverse events caused by type 2 diabetes: Study expresspharma
November 04, 2020
IIT Mandi researchers find that low-dose naltrexone (LDN) can activate SIRT1, a critical protein molecule, thereby reducing inflammation and increasing insulin sensitivity of cells.
Merck Manuals Shares What Parents Need to Know About Adolescent Prediabetes prnewswire
October 30, 2020
Nearly one in five adolescents are living with prediabetes. Prediabetes is a critical warning sign in children at risk of developing type 2 diabetes.
Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets expresspharma
October 30, 2020
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus.
Zydus Cadila gets tentative US FDA approval for Dapagliflozin Tablets expresspharma
October 30, 2020
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to improve glycemic control in adults with type 2 diabetes mellitus.
Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment prnasia
September 30, 2020
Daewoong Pharmaceutical (Daewoong) (CEO Sengho Jeon) announced the result of its phase 2 clinical trial on enavogliflozin, SGLT2 inhibitor for diabetes currently in the process of development, for the first time at the ...